INR vs. HRMY
INR (Infinity Natural Resources, Inc) and HRMY (Harmony Biosciences Holdings, Inc.) are both stocks. INR operates in Oil & Gas E&P (Energy), while HRMY operates in Biotechnology (Healthcare). Over the past year, INR returned -23.22% vs -9.09% for HRMY. At a 0.02 correlation, their price movements are largely independent.
Performance
INR vs. HRMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INR achieves a -10.45% return, which is significantly higher than HRMY's -14.22% return.
INR
- 1D
- -0.08%
- 1M
- -23.98%
- YTD
- -10.45%
- 6M
- -7.96%
- 1Y
- -23.22%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
HRMY
- 1D
- 3.85%
- 1M
- -1.50%
- YTD
- -14.22%
- 6M
- -13.24%
- 1Y
- -9.09%
- 3Y*
- -3.02%
- 5Y*
- -0.67%
- 10Y*
- —
INR vs. HRMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
INR Infinity Natural Resources, Inc | -10.45% | -30.09% |
HRMY Harmony Biosciences Holdings, Inc. | -14.22% | -3.48% |
Correlation
The correlation between INR and HRMY is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.05 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2025 | 0.02 |
Fundamentals
INR:
$3.01
HRMY:
$2.48
INR:
4.38
HRMY:
12.93
INR:
0.49
HRMY:
2.09
INR:
$426.14M
HRMY:
$899.11M
INR:
$200.85M
HRMY:
$688.25M
INR:
$334.14M
HRMY:
$221.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INR vs. HRMY — Risk / Return Rank
INR
HRMY
INR vs. HRMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Infinity Natural Resources, Inc (INR) and Harmony Biosciences Holdings, Inc. (HRMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| INR | HRMY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.49 | -0.22 | -0.27 |
Sortino ratioReturn per unit of downside risk | -0.46 | -0.02 | -0.44 |
Omega ratioGain probability vs. loss probability | 0.95 | 1.00 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | -0.55 | -0.26 | -0.28 |
Martin ratioReturn relative to average drawdown | -0.93 | -0.49 | -0.44 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| INR | HRMY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.49 | -0.22 | -0.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.01 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.60 | -0.05 | -0.56 |
Drawdowns
INR vs. HRMY - Drawdown Comparison
The maximum INR drawdown since its inception was -48.84%, smaller than the maximum HRMY drawdown of -68.48%. Use the drawdown chart below to compare losses from any high point for INR and HRMY.
Loading charts...
Drawdown Indicators
| INR | HRMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.84% | -68.48% | +19.64% |
Max Drawdown (1Y)Largest decline over 1 year | -42.74% | -34.49% | -8.25% |
Max Drawdown (3Y)Largest decline over 3 years | — | -50.81% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.48% | — |
Current DrawdownCurrent decline from peak | -39.74% | -47.30% | +7.56% |
Average DrawdownAverage peak-to-trough decline | -28.50% | -35.20% | +6.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.09% | 18.69% | +6.40% |
Volatility
INR vs. HRMY - Volatility Comparison
Infinity Natural Resources, Inc (INR) has a higher volatility of 14.58% compared to Harmony Biosciences Holdings, Inc. (HRMY) at 10.05%. This indicates that INR's price experiences larger fluctuations and is considered to be riskier than HRMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INR | HRMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.58% | 10.05% | +4.53% |
Volatility (6M)Calculated over the trailing 6-month period | 32.68% | 30.17% | +2.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.16% | 41.40% | +5.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.22% | 50.04% | -0.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.22% | 52.40% | -3.18% |
Dividends
INR vs. HRMY - Dividend Comparison
Neither INR nor HRMY has paid dividends to shareholders.
Financials
INR vs. HRMY - Financials Comparison
This section allows you to compare key financial metrics between Infinity Natural Resources, Inc and Harmony Biosciences Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INR vs. HRMY - Profitability Comparison
INR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Infinity Natural Resources, Inc reported a gross profit of 86.75M and revenue of 154.87M. Therefore, the gross margin over that period was 56.0%.
HRMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a gross profit of 170.88M and revenue of 215.39M. Therefore, the gross margin over that period was 79.3%.
INR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Infinity Natural Resources, Inc reported an operating income of 78.83M and revenue of 154.87M, resulting in an operating margin of 50.9%.
HRMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported an operating income of 37.29M and revenue of 215.39M, resulting in an operating margin of 17.3%.
INR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Infinity Natural Resources, Inc reported a net income of -1.87M and revenue of 154.87M, resulting in a net margin of -1.2%.
HRMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Harmony Biosciences Holdings, Inc. reported a net income of 32.49M and revenue of 215.39M, resulting in a net margin of 15.1%.
Frequently Asked Questions
INR and HRMY have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INR has higher volatility (14.58%) compared to HRMY (10.05%). In terms of maximum drawdown, INR dropped -48.84% vs HRMY's -68.48%.
HRMY currently has the higher Sharpe Ratio (-0.22 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INR and HRMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer